MRC — Mercator Medical SA Balance Sheet
0.000.00%
- PLN360.56m
- PLN261.94m
- PLN542.49m
- 88
- 98
- 17
- 81
Annual balance sheet for Mercator Medical SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 400 | 340 | 223 | 217 | 123 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 340 | 126 | 71.1 | 105 | 170 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,096 | 914 | 698 | 585 | 635 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 183 | 336 | 285 | 255 | 311 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,289 | 1,289 | 1,083 | 965 | 1,043 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 240 | 133 | 60 | 78.5 | 96.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 249 | 145 | 74.3 | 103 | 115 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,040 | 1,144 | 1,009 | 862 | 928 |
| Total Liabilities & Shareholders' Equity | 1,289 | 1,289 | 1,083 | 965 | 1,043 |
| Total Common Shares Outstanding |